Clinical trial / 2016
Black raspberry extract decreased radial augmentation index and increased circulating EPCs in patients with metabolic syndrome over 12 weeks.
Fifty-one patients with metabolic syndrome were randomized to receive 750 mg/day of black raspberry extract (n = 26) or placebo (n = 25) for 12 weeks. Radial augmentation indexes significantly decreased in the black raspberry group compared with placebo (-5% ± 10% vs. 3% ± 14%, P < .05), and CD34/CD133(+) cells were significantly higher (19 ± 109/μL vs. -28 ± 57/μL, P < .05). Additionally, the black raspberry group showed significantly greater decreases in IL-6 (-0.5 ± 1.4 pg/mL vs. -0.1 ± 1.1 pg/mL) and TNF-α (-5.4 ± 4.5 pg/mL vs. -0.8 ± 4.0 pg/mL), along with significant increases in adiponectin (2.9 ± 2.1 μg/mL vs. -0.2 ± 2.5 μg/mL).
- Study type
- Randomized controlled trial
- Who was studied
- 51 patients with metabolic syndrome
- What was measured
- Circulating endothelial progenitor cells, arterial stiffness, and biomarkers
THE PAPER
Black Raspberry Extract Increased Circulating Endothelial Progenitor Cells and Improved Arterial Stiffness in Patients with Metabolic Syndrome: A Randomized Controlled Trial.
Jeong HS, Kim S, Hong SJ, Choi SC, Choi JH, Kim JH, Park CY, Cho JY, Lee TB, Kwon JW, Joo HJ, Park JH, Yu CW, Lim DS. J Med Food, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.